#scleroderma 검색 결과

Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma

Drasiri1000's tweet image. Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri
was accepted at #ACR25 – Chicago 🇺🇸!

The world’s main rheumatology conference, covering both adult & pediatric advances.
A proud step forward in improving care for young patients. 

#Scleroderma…

Systemic Sclerosis–Associated ILD Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim buff.ly/w9qmEr7 #ILD #Scleroderma

RheumNow's tweet image. Systemic Sclerosis–Associated ILD

Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim 

buff.ly/w9qmEr7 

#ILD #Scleroderma

Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

ClaireDeVille3's tweet image. Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…

IlliasulK's tweet image. 🧵1/
👁 Ever wanted to see autoimmune Microvascular dysfunction in action?

Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs.

Let’s walk through what it reveals in #Scleroderma.…

2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

sclerodermasara's tweet image. 2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma 
I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.

sclerodermaUM's tweet image. Excited to present  WIN  #scleroderma #eular2025. This slide highlights the opportunities in drug development in  SSc. Come and join on Saturday 6/14 at 9 AM CET.

Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.

sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.

The 3rd #Scleroderma_preceptorship_program The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐 Big thanks to: Patients, attendees, speakers and chairpersons @ssrsa_org for facilitating @Boehringer

WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…

Prophylactic ACEi in #Scleroderma? No benefit, worse outcomes in renal crisis! #Rheumatology #MedTwitter #BSR25

LastManStand85's tweet image. Prophylactic ACEi in #Scleroderma?

No benefit, worse outcomes in renal crisis!

#Rheumatology #MedTwitter #BSR25

🧵 Skin Manifestations of Systemic Sclerosis (SSc) The skin is often the first—and most revealing—organ affected. Here’s a layered look at what to watch for 👇 #Rheumatology #Scleroderma #MedTwitter @IhabFathiSulima @Janetbirdope @DrAkhilX @Drkhenaizan @MattersRheum

Rheumat_Aravind's tweet image. 🧵 Skin Manifestations of Systemic Sclerosis (SSc)
The skin is often the first—and most revealing—organ affected. Here’s a layered look at what to watch for 👇
#Rheumatology #Scleroderma #MedTwitter @IhabFathiSulima @Janetbirdope @DrAkhilX @Drkhenaizan @MattersRheum

Controversies afternoon keynote lecture delivered by @MarbanLab discussing the development of a new #ncRNA drug to treat #Scleroderma/#SystemicSclerosis

SmidtHeart's tweet image. Controversies afternoon keynote lecture delivered by @MarbanLab discussing the development of a new #ncRNA drug to treat #Scleroderma/#SystemicSclerosis
SmidtHeart's tweet image. Controversies afternoon keynote lecture delivered by @MarbanLab discussing the development of a new #ncRNA drug to treat #Scleroderma/#SystemicSclerosis
SmidtHeart's tweet image. Controversies afternoon keynote lecture delivered by @MarbanLab discussing the development of a new #ncRNA drug to treat #Scleroderma/#SystemicSclerosis

🎊 Congratulations to Dr @Huda_Alfaris on the successful completion of the @UofTRheum #Scleroderma Fellowship! @SchroederInst @UHN_Research @SclerodermaCAN @CSRG2022

SindhuJohnson5's tweet image. 🎊 Congratulations to Dr @Huda_Alfaris on the successful completion of the @UofTRheum #Scleroderma Fellowship! @SchroederInst @UHN_Research @SclerodermaCAN @CSRG2022

While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

SindhuJohnson5's tweet image. While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

🆕CD19 CAR T Cell treatment -A potentially promising future treatment in #SLE #scleroderma #myositis -Needs close collaboration with haematology Great explanation by @chriswincup #ACR24 #Lupus #SystemicSclerosis #IIM

gurdeep_dulay's tweet image. 🆕CD19 CAR T Cell treatment

-A potentially promising future treatment in #SLE #scleroderma #myositis 

-Needs close collaboration with haematology

Great explanation by @chriswincup #ACR24  #Lupus #SystemicSclerosis #IIM

Sastanak grupe za sistemsku sklerozu 13.11.2025. na kojem je gost bila prof. dr Dragana Jovanović, internista-pulmolog, možete pogledati na YouTube kanalu youtu.be/sxNIyZXLlxA?si… i na sajtu ors.rs u odeljku vesti. #scleroderma #plucnafibroza #reumatologija

StopArtritis's tweet image. Sastanak grupe za sistemsku sklerozu 13.11.2025. na kojem je gost bila prof. dr Dragana Jovanović, internista-pulmolog, možete pogledati na YouTube kanalu
youtu.be/sxNIyZXLlxA?si…
i na sajtu ors.rs u odeljku vesti.

#scleroderma
#plucnafibroza
#reumatologija

Important data for SSc-ILD community: PFD added to MMF didn’t yield significant FVC gains, but trends in physical function are worth noting. Highlights the ongoing need for robustly powered studies to refine combination therapy strategies. #Ssc #Scleroderma #ILD #SARDILD

Randomized phase 2 trial of pirfenidone (PFD) or placebo along with MMF in SSc-ILD: doi.org/10.1002/acr2.7… • no statistically or clinically significant difference in FVC% improvement from baseline • mean time to ≥3% improvement in FVC% was numerically shorter with MMF+PFD •…

ACR_Journals's tweet image. Randomized phase 2 trial of pirfenidone (PFD) or placebo along with MMF in SSc-ILD:
doi.org/10.1002/acr2.7…
• no statistically or clinically significant difference in FVC% improvement from baseline
• mean time to ≥3% improvement in FVC% was numerically shorter with MMF+PFD
•…


👉 Our December literature search identified 94 new papers in #Scleroderma! View the results by clicking the link here: 🔗scleroderma-forum.com/resources

ScleroForum's tweet image. 👉 Our December literature search identified 94 new papers in #Scleroderma!

View the results by clicking the link here: 🔗scleroderma-forum.com/resources

Une voie moléculaire identifiée comme facteur clé de la cicatrisation dans la #sclérodermie.#scleroderma Étude : Les traitements inhibiteurs pourraient contribuer à atténuer la fibrose dans de nombreuses pathologies sclerodermanews.com/news/molecular…


There are many #nutrition challenges for people with #systemicsclerosis. Our most recent article in collaboration with colleagues from @Aristoteleio, @unithessaly and @harokopio_ , explores these in detail: mdpi.com/2072-6643/17/1… @WeAreSRUK #scleroderma


Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. Access these valuable resources today: 🔗ow.ly/iAxi50XrF53

ScleroForum's tweet image. Looking for the latest insights in #scleroderma? Our new slide deck and literature highlights are live on the #SclerodermaForum. 

Access these valuable resources today: 🔗ow.ly/iAxi50XrF53

What do scleroderma & PH have in common? A lot. Kate Salonga shares her takeaways from the Scleroderma BC 2025 AGM—and why rare disease communities need to learn from each other. 👉 Read: ow.ly/RoHN50XyMVi #RareDisease #PHACanada #Scleroderma #PulmonaryHypertension

PHACanada's tweet image. What do scleroderma & PH have in common? A lot.

Kate Salonga shares her takeaways from the Scleroderma BC 2025 AGM—and why rare disease communities need to learn from each other.

👉 Read: ow.ly/RoHN50XyMVi

#RareDisease #PHACanada #Scleroderma #PulmonaryHypertension

If you've read my blog 1 Day 1 Week you know my mom has #Scleroderma & related Interstitial Lung Disease. Another beautiful mom -- this one of @IAMQUEENLATIFAH also suffered from these & is the inspiration behind this wonderful, important video. youtu.be/flHQSBc6KQ4

1day1weekblog's tweet image. If you've read my blog 1 Day 1 Week you know my mom has #Scleroderma & related Interstitial Lung Disease. Another beautiful mom -- this one of @IAMQUEENLATIFAH also suffered from these & is the inspiration behind this wonderful, important video.
youtu.be/flHQSBc6KQ4

Dive into the latest research on #scleroderma with our new in-depth slide deck and literature highlights! Available now for free on the #SclerodermaForum: 🔗ow.ly/SUHJ50XrF3M

ScleroForum's tweet image. Dive into the latest research on #scleroderma with our new in-depth slide deck and literature highlights! 

Available now for free on the #SclerodermaForum: 🔗ow.ly/SUHJ50XrF3M

This insightful study explores endothelial cell heterogeneity and #ImmuneMetabolic interactions in scleroderma using single-cell RNA sequencing. #Scleroderma #SingleCellRNA #PrecisionMedicine @ZainKhalpey @sclerodermaUM @SclerodermaCAN @SclerodermaNews @Worldsclerofnd

🧫 Endothelial cell heterogeneity in scleroderma 🔍 Insights from single-cell RNA sequencing ⚡ Reveals immune-metabolic interactions 🧠 Potential for novel therapeutic targets #EndothelialCells #SingleCellRNA #Immunometabolism 👉Read more: oaepublish.com/articles/2574-…

Vessel_Plus's tweet image. 🧫 Endothelial cell heterogeneity in scleroderma
🔍 Insights from single-cell RNA sequencing
⚡ Reveals immune-metabolic interactions
🧠 Potential for novel therapeutic targets
#EndothelialCells #SingleCellRNA #Immunometabolism

👉Read more:  oaepublish.com/articles/2574-…


#Scleroderma and #SIBO present an intriguing challenge. The connection between systemic sclerosis and microbial imbalance in the gut is crucial for symptom management. Have you seen recent studies highlighting bacterial culture analysis in SSc patients? This ties into broader…


Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma

Drasiri1000's tweet image. Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri
was accepted at #ACR25 – Chicago 🇺🇸!

The world’s main rheumatology conference, covering both adult & pediatric advances.
A proud step forward in improving care for young patients. 

#Scleroderma…

Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

ClaireDeVille3's tweet image. Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

Systemic Sclerosis–Associated ILD Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim buff.ly/w9qmEr7 #ILD #Scleroderma

RheumNow's tweet image. Systemic Sclerosis–Associated ILD

Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim 

buff.ly/w9qmEr7 

#ILD #Scleroderma

Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients! @CedarsSinaiMed

MarbanLab's tweet image. Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients!
@CedarsSinaiMed

Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…

MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…

Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.

sclerodermaUM's tweet image. Excited to present  WIN  #scleroderma #eular2025. This slide highlights the opportunities in drug development in  SSc. Come and join on Saturday 6/14 at 9 AM CET.

#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]

LastManStand85's tweet image. #Scleroderma specific autoantibodies in predicting prognosis/survival 

➡️ almost all #ANA positive

📈 Best survival in anticentromere group
 
📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present 

[AL Herrick]

Big kudos to our esteemed faculty members @RobFairchildMD & @ChungLorinda, for their outstanding presentations at the 8th Scleroderma World Congress in Prague last weekend! Proud moment for @StanfordMed showcasing expertise in #rheumatology #scleroderma #POCUS #ILD #MSKUS.

StanfordRheum's tweet image. Big kudos to our esteemed faculty members @RobFairchildMD & @ChungLorinda, for their outstanding presentations at the 8th Scleroderma World Congress in Prague last weekend! Proud moment for @StanfordMed showcasing expertise in #rheumatology #scleroderma #POCUS #ILD #MSKUS.
StanfordRheum's tweet image. Big kudos to our esteemed faculty members @RobFairchildMD & @ChungLorinda, for their outstanding presentations at the 8th Scleroderma World Congress in Prague last weekend! Proud moment for @StanfordMed showcasing expertise in #rheumatology #scleroderma #POCUS #ILD #MSKUS.
StanfordRheum's tweet image. Big kudos to our esteemed faculty members @RobFairchildMD & @ChungLorinda, for their outstanding presentations at the 8th Scleroderma World Congress in Prague last weekend! Proud moment for @StanfordMed showcasing expertise in #rheumatology #scleroderma #POCUS #ILD #MSKUS.

🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…

IlliasulK's tweet image. 🧵1/
👁 Ever wanted to see autoimmune Microvascular dysfunction in action?

Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs.

Let’s walk through what it reveals in #Scleroderma.…

Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

Prophylactic ACEi in #Scleroderma? No benefit, worse outcomes in renal crisis! #Rheumatology #MedTwitter #BSR25

LastManStand85's tweet image. Prophylactic ACEi in #Scleroderma?

No benefit, worse outcomes in renal crisis!

#Rheumatology #MedTwitter #BSR25

On #WorldSclerodermaDay let's spread awareness about #Scleroderma! Early diagnosis focuses on detecting symptomatic patients as early as possibile, it is the key to make a significant difference in treatment outcomes!

EmanuelaPraino's tweet image. On #WorldSclerodermaDay let's spread awareness about #Scleroderma! Early diagnosis focuses on detecting symptomatic patients as early as possibile, it is the key to make a significant difference in treatment outcomes!

Alain Lescoat sharing new PRO for limited #scleroderma! #acr2024 Thanks to SCTC, ⁦@Worldsclerofnd⁩ ⁦@Fscleroderma⁩ and ⁦@srfcure⁩ for supporting the work

sclerodermaUM's tweet image. Alain Lescoat sharing new PRO for limited #scleroderma! #acr2024 Thanks to SCTC, ⁦@Worldsclerofnd⁩ ⁦@Fscleroderma⁩ and ⁦@srfcure⁩ for supporting the work

My dear son in law. Waiting for #lungtransplant #scleroderma #VGH grateful to donors grateful to doctors

karen_kelowna's tweet image. My dear son in law. Waiting for #lungtransplant #scleroderma
#VGH grateful to donors grateful to doctors

#OTWeek2023 "It sounds daft doesn't it...but that's the thing I most want to be able to do again" How would you feel if you couldn't hold a cup of tea to enjoy a brew? Working with this #scleroderma patient to find a mug that he can hold himself @SalfordCO_NHS @RCOT_TMH @theRCOT

CathMcCoy's tweet image. #OTWeek2023
"It sounds daft doesn't it...but that's the thing I most want to be able to do again"
How would you feel if you couldn't hold a cup of tea to enjoy a brew? Working with this #scleroderma patient to find a mug that he can hold himself @SalfordCO_NHS @RCOT_TMH @theRCOT

#scleroderma 1. why is SSc- a 'fibrotic disease' treated with immunosuppressive? 2. Why dont every patient with early SSc respond to immunosuppressive? the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity. @IRACON24Blr

sclerodermaUM's tweet image. #scleroderma 
1. why is SSc- a 'fibrotic disease' treated with immunosuppressive?
2. Why dont every patient with early SSc respond to immunosuppressive? 
the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity.  @IRACON24Blr
sclerodermaUM's tweet image. #scleroderma 
1. why is SSc- a 'fibrotic disease' treated with immunosuppressive?
2. Why dont every patient with early SSc respond to immunosuppressive? 
the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity.  @IRACON24Blr

Loading...

Something went wrong.


Something went wrong.


United States Trends